Sign In
Buy BIIB
$196.45
+0.490 (+0.250%)
At Close: Jun 04, 2026
BIIB STOCKHOLDERS: Lead Plaintiff Deadline Approaching in Biogen Inc. Class Action; Contact Robbins LLP
04:02pm, Tuesday, 02'nd Jul 2024
SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Biogen Inc.
Eli Lilly Snags Long-Awaited Alzheimer's Drug Approval, Rivaling Biogen, Eisai
02:16pm, Tuesday, 02'nd Jul 2024
Eli Lilly won FDA approval for its Alzheimer's treatment, donanemab, on Tuesday. But Eli Lilly stock remained in the red.
Shareholders that lost money on Biogen Inc. (BIIB) should contact Levi & Korsinsky about pending Class Action - BIIB
12:35pm, Tuesday, 02'nd Jul 2024
NEW YORK, July 02, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) of a class action securities lawsuit.
This cheap biotech offers investors a play on ALS if trial data continues to impress
12:34pm, Tuesday, 02'nd Jul 2024
NeuroSense Therapeutics Ltd.'s stock rose 6.5% Tuesday, as analysts cheered data from the biotech's late-stage trial of a treatment for the fatal disease amyotrophic lateral sclerosis, or ALS.
Biogen Inc. Sued for Securities Law Violations - Contact the Schall Law Firm to Discuss Your Legal Rights BIIB
12:00pm, Tuesday, 02'nd Jul 2024
LOS ANGELES , July 2, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Biogen Inc. ("Biogen" or "the Com
Shareholders of Biogen Inc. Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB
11:45am, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Firm
11:10am, Tuesday, 02'nd Jul 2024
LOS ANGELES, July 02, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Biogen Inc. (“Biogen” or “t
July 22, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - BIIB
10:15am, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
Biogen Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - BIIB
10:15am, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
NEW YORK , July 2, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) and certain officers. The cl
Securities Fraud Class Action Lawsuit Was Filed Against Biogen Inc. (BIIB) - Contact Kessler Topaz Meltzer & Check, LLP
09:45am, Tuesday, 02'nd Jul 2024
RADNOR, PA / ACCESSWIRE / July 2, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States D
Biogen Completes Acquisition of Human Immunology Biosciences
09:16am, Tuesday, 02'nd Jul 2024
CAMBRIDGE, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology
July 22, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BIIB
05:15am, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
Biogen Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - BIIB
05:15am, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
UPCOMING BIIB DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Biogen Inc. Investors to Join the Class Action Lawsuit!
05:00am, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Biogen Inc. ("Bio
